The Relationship Between Medication Burden and 30-day Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation-Reference-Cited by-同舟云学术

The Relationship Between Medication Burden and 30-day Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation

Published:2024-03-01 Issue:1 Volume:5 Page:21-28
ISSN:2718-0956
Container-title:Hamidiye Medical Journal
language:
Short-container-title:hamidiyemedj

Author:

Güler Arda^ORCID,Gürbak İsmail^ORCID,Altunova Mehmet^ORCID,Demir Ali Rıza^ORCID,Tükenmez Karakurt Seda^ORCID,Doğan Abdullah^ORCID,Demirci Gökhan^ORCID,Aslan Serkan^ORCID,Kalkan Ali Kemal^ORCID,Babur Güler Gamze^ORCID,Ertürk Mehmet^ORCID

Publisher

Galenos Yayinevi

Reference26 articles.

1. 1. Vogt F, Wicklein S, Gosch M, Jessl J, Hitzl W, Fischlein T, et al. Functionality and Outcome in Older Patients with Severe Aortic Stenosis (FOOPAS): an interdisciplinary study concept for a prospective trial. Clin Interv Aging. 2018;13:185-193. [Crossref]

2. 2. Swift SL, Puehler T, Misso K, Lang SH, Forbes C, Kleijnen J, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis. BMJ Open. 2021;11:e054222. [Crossref]

3. 3. Khatri PJ, Webb JG, Rodés-Cabau J, Fremes SE, Ruel M, Lau K, et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med. 2013;158:35-46. [Crossref]

4. 4. Bagur R, Martin GP, Nombela-Franco L, Doshi SN, George S, Toggweiler S, et al. Association of comorbid burden with clinical outcomes after transcatheter aortic valve implantation. Heart. 2018;104:2058-2066. [Crossref]

5. 5. Anand SS, Caron F, Eikelboom JW, Bosch J, Dyal L, Aboyans V, et al. Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial. J Am Coll Cardiol. 2018;71:2306-2315. [Crossref]